NCT06748703 - Optic Nerve Injury in Obstructive Sleep Apnea Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Obstructive Sleep Apnea (OSA)Ischemic Optic Neuropathy/Optic Nerve Stroke

Interventions

DEVICE

CPAP Treatment

CPAP therapy will be administered to patients for 3 months. The CPAP device will be set to deliver a continuous flow of air at a prescribed pressure to keep the patient's airway open during sleep.

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing